A designer peptide against the EAG2-Kvβ2 potassium channel targets the interaction of cancer cells and neurons to treat glioblastoma.
Dong W, Fekete A, Chen X, Liu H, Beilhartz GL, Chen X, Bahrampour S, Xiong Y, Yang Q, Zhao H, Kong T, Morioka MS, Jung G, Kim JE, Schramek D, Dirks PB, Song Y, Kim TH, He Y, Wanggou S, Li X, Melnyk RA, Wang LY, Huang X.
Dong W, et al. Among authors: chen x.
Nat Cancer. 2023 Oct;4(10):1418-1436. doi: 10.1038/s43018-023-00626-8. Epub 2023 Sep 11.
Nat Cancer. 2023.
PMID: 37697045